2m 2m 2m 2m 2m 2m 2m
Xenon Pharma (XENE)
NASDAQ
$59.00+$0.35 (+0.60%)
Price as of Sep 11, 2026 7:30 PM EDT- $5.7BMarket Cap
- 61.97%1-Year Change
- BiotechnologyIndustry
Xenon Pharma (XENE)
$59.00+$0.35 (+0.60%)
XENE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $58.65 | ||
Change | -$0.15 (-0.26%) | ||
Open | $60.00 | ||
High | $60.00 | ||
Low | $58.53 | ||
Previous Close | $58.80 | ||
Volume | 466,754 | ||
30-Day Average Volume | 654,588 | ||
1-Week Change | -1.84% | ||
1-Month Change | -7.23% | ||
1-Year Change | 61.97% | ||
3-Year Change | 56.90% | ||
5-Year Change | 236.10% | ||
Fundamentals | |||
Shares Outstanding | 96.8M | ||
Total Assets | $1.3B | ||
Market Cap | $5.7B | ||
Enterprise Value | $5.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$110.7M | ||
Free Cash Flow | -$95.7M | ||
EBIT | -$111.3M | ||
EBITDA | -$110.8M | ||
Net Working Capital | $900.9M | ||
EPS | -$1.11 | ||
Enterprise Value/EBITDA | -50 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -53 | ||
PEG | -10 | ||
Price/Free Cash Flow | -59 | ||
Price/Operating Cash Flow | -60 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue